ATRX News and Press, Adhera Therapeutics Inc From 04/04/19

Thinly traded specialty pharmaceutical company Adhera Therapeutics ( OTCQB:ATRX ) appoints Nancy Phelan as the new Chief Executive Officer of the Company More news on: Adhera Therapeutics, Inc., Healthcare stocks news Read more ...

RESEARCH TRIANGLE PARK, NC, April 04, 2019 (GLOBE NEWSWIRE) -- Adhera Therapeutics, Inc. (OTCQB: ATRX), a specialty pharmaceutical company leveraging technology to commercialize unique therapies and improve patient outcomes, today announced that its Board of Directors has appointed Nancy R....

RESEARCH TRIANGLE PARK, NC and NEW YORK, NY / ACCESSWIRE / March 4, 2019 / Adhera Therapeutics (OTCQB: ATRX), a specialty pharmaceutical company leveraging technology to commercialize unique therapies and improve patient outcomes, and Alyvant, a company focused on tech-enabled pharma commerc...

Over 200 prescribers have written at least one prescription for PRESTALIA and over 600 patients are taking the medication PRESTALIA was launched in Q3 2018, powered by the Company's proprietary DyrctAxess platform RESEARCH TRIANGLE PARK, NC / ACCESSWIRE / February 6, 2019 / Adhera Ther...